The potential relationship between uric acid and the recovery in sudden sensorineural hearing loss
•Hyperuricemia is an independent risk factor for hearing recovery in SSNHL.•Serum uric acid levels negatively affect hearing outcome in SSNHL.•Initial hearing threshold is a risk factor for SSNHL recovery. Serum uric acid is proven to be associated with chronic hearing loss, but its effect on Sudden...
Gespeichert in:
Veröffentlicht in: | Brazilian journal of otorhinolaryngology 2024-01, Vol.90 (1), p.101368-101368, Article 101368 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | •Hyperuricemia is an independent risk factor for hearing recovery in SSNHL.•Serum uric acid levels negatively affect hearing outcome in SSNHL.•Initial hearing threshold is a risk factor for SSNHL recovery.
Serum uric acid is proven to be associated with chronic hearing loss, but its effect on Sudden Sensorineural Hearing Loss (SSNHL) is unclear. This study aims to evaluate the prognostic values of serum uric acid levels in SSNHL patients.
The clinical records of SSNHL patients were retrospectively reviewed. Patients were divided into different groups based on hearing recovery and audiogram type, and uric acid levels were compared. Based on uric acid levels, patients were categorized into normouricemia and hyperuricemia groups, and clinical features and hearing recovery were evaluated. Univariate and multivariate analyses were performed to identify prognostic factors.
In total, 520 SSNHL patients were included in this study, including 226 females and 294 males. In female patients, 186 patients were included in the normouricemia group, and 40 patients were enrolled in the hyperuricemia group. Significant differences were observed in uric acid levels, Total Cholesterol (TC), rate of complete recovery, and slight recovery between the two groups. In male patients, 237 subjects were categorized into the normouricemia group, and 57 patients were included in the hyperuricemia group. The rate of complete recovery and slight recovery was lower in the hyperuricemia group compared to the normouricemia group. All patients were further divided into good recovery and poor recovery groups based on hearing outcomes. The uric acid levels, initial hearing threshold, rate of hyperuricemia, and TC were lower in the good recovery group than the poor recovery group both in female and male patients. Binary logistic regression results showed that uric acid levels, initial hearing threshold, and hyperuricemia were associated with hearing recovery.
Hyperuricemia might be an independent risk factor for hearing recovery in SSNHL patients. Serum uric acid and initial hearing threshold possibly affected the hearing outcome in males and females with SSNHL.
Level 4. |
---|---|
ISSN: | 1808-8694 1808-8686 1808-8686 |
DOI: | 10.1016/j.bjorl.2023.101368 |